Further to an earlier posting about Merck and Elsevier combining on a fake journal, Elsevier now acknowledges that there were six "sponsored article publications."
Elsevier Published Six Fake Journals
May 8, 2009
Share this post
2 Comments

Law Bytes
Episode 260: What the Government Didn’t Want You To Hear About Bill C-4 And Its Weak Political Party Privacy Rules
byMichael Geist

March 2, 2026
Michael Geist
February 23, 2026
Michael Geist
February 9, 2026
Michael Geist
Episode 256: Jennifer Quaid on Taking On Big Tech With the Competition Act's Private Right of Access
February 2, 2026
Michael Geist
Search Results placeholder
Recent Posts
The Law Bytes Podcast, Episode 260: What the Government Didn’t Want You To Hear About Bill C-4 And Its Weak Political Party Privacy Rules
Why the Online Harms Act is the Wrong Way to Regulate AI Chatbots
More Transparency Not Police Reporting: Navigating the Safety-Privacy Balance for AI ChatBots
The Law Bytes Podcast, Episode 259: The Privacy and Surveillance Risks of AI Chatbot Reporting to Police
Nobody Wants This: Senate Rejects Government’s Anti-Privacy Plan for Political Parties By Sending Bill Back to the House With a Sunset Clause

Use bugmenot to read the article
If you do not want to register just to read an article, use bugmenot.com to enter the-scientist site.
Sick and tired of walled gardens like Elsevier? Support Science Commons
http://sciencecommons.org/about/
Quote:
There are petabytes of research data being produced in laboratories around the world, but the best web search tools available can’t help us make sense of it. Why? Because more stands between basic research and meaningful discovery than the problem of search.
Many scientists today work in relative isolation, left to follow blind alleys and duplicate existing research. Data are balkanized — trapped behind firewalls, locked up by contracts or lost in databases that can’t be accessed or integrated. Materials are hard to get — universities are overwhelmed with transfer requests that ought to be routine, while grant cycles pass and windows of opportunity close. It’s not uncommon for research sponsors to invest hundreds of millions of dollars in critically important efforts like drug discovery, only to see them fail.
The consequences in many cases are no less than tragic. The time it takes to go from identifying a gene to developing a drug currently stands at 17 years — forever, for people suffering from disease.